Zevra Therapeutics, Inc. (ZVRA) on GreekSoup https://greeksoup.ai/stocks/us/zvra/ Every dated entry in the public record on Zevra Therapeutics, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Fri, 30 Oct 2026 00:00:00 +0000 Zevra Therapeutics, Inc.: short interest 6,226,029 shares at the 15 October 2026 settlement, 7.08 days to coverhttps://greeksoup.ai/stocks/us/zvra/short-interest/us:ZVRA:short-interest:2026-10-15:92e6f0a1e7Thu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Zevra Therapeutics, Inc.: Form 144, NEIL F MCFARLANE plans to sell 20,000 shares worth $227,800 around 12 October 2026https://greeksoup.ai/stocks/us/zvra/planned-sales/us:ZVRA:planned-sale:2026-10-13:bafec9c8bfTue, 13 Oct 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Zevra Therapeutics, Inc.: Mcfarlane Neil F. (President and CEO) sold 20,000 shares (under a trading plan set in advance) at $11.25 on 12 October 2026, $224,948https://greeksoup.ai/stocks/us/zvra/insiders/us:ZVRA:insider:2026-10-13:644c7e4c7fTue, 13 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Zevra Therapeutics, Inc.: short interest 7,147,220 shares at the 30 September 2026 settlement, 7.16 days to coverhttps://greeksoup.ai/stocks/us/zvra/short-interest/us:ZVRA:short-interest:2026-09-30:0c8fe0bfecWed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Zevra Therapeutics, Inc.: short interest 5,738,663 shares at the 15 September 2026 settlement, 6.33 days to coverhttps://greeksoup.ai/stocks/us/zvra/short-interest/us:ZVRA:short-interest:2026-09-15:3f83a2dcb3Tue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Zevra Therapeutics, Inc.: short interest 5,771,206 shares at the 31 August 2026 settlement, 7.46 days to coverhttps://greeksoup.ai/stocks/us/zvra/short-interest/us:ZVRA:short-interest:2026-08-31:208612a3d9Mon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Zevra Therapeutics, Inc.: Thompson Rahsaan (Chief Legal & Compliance) sold 42,666 shares (under a trading plan set in advance) at $11.13 on 14 August 2026, $474,774https://greeksoup.ai/stocks/us/zvra/insiders/us:ZVRA:insider:2026-08-17:b5f7594526Mon, 17 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Zevra Therapeutics, Inc.: Form 144, RAHSAAN THOMPSON plans to sell 42,666 shares worth $477,006 around 14 August 2026https://greeksoup.ai/stocks/us/zvra/planned-sales/us:ZVRA:planned-sale:2026-08-14:ac8a46752bFri, 14 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Zevra Therapeutics, Inc.: Schedule 13G/A filed by Woodline Partners LP, 8.1% of the classhttps://greeksoup.ai/stocks/us/zvra/holders/us:ZVRA:schedule-13:2026-08-14:be06966940Fri, 14 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Zevra Therapeutics, Inc.: short interest 6,470,662 shares at the 14 August 2026 settlement, 5.76 days to coverhttps://greeksoup.ai/stocks/us/zvra/short-interest/us:ZVRA:short-interest:2026-08-14:056aacaf96Fri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Zevra Therapeutics, Inc.: Watton Corey Michael (Director) sold 12,300 shares at $11.25 on 10 August 2026, $138,377https://greeksoup.ai/stocks/us/zvra/insiders/us:ZVRA:insider:2026-08-12:71cb4a679fWed, 12 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Zevra Therapeutics, Inc.: Schedule 13G/A filed by FMR LLC, 8.3% of the classhttps://greeksoup.ai/stocks/us/zvra/holders/us:ZVRA:schedule-13:2026-08-06:5b6cd369a6Thu, 06 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Zevra Therapeutics, Inc. Q2 FY2026 results: revenue $40 million, net income $9 millionhttps://greeksoup.ai/stocks/us/zvra/results/fy2026-q2/us:ZVRA:result:2026-08-05:668d6a7ad0Wed, 05 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Zevra Therapeutics, Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/zvra/filings/us:ZVRA:filing:2026-08-05:ca63f7f691Wed, 05 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Zevra Therapeutics, Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/zvra/filings/us:ZVRA:filing:2026-08-05:838e2f4181Wed, 05 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]>